Farmaceutica Evolucion Llp - Company Profile

It is a business services limited liability partnership based in Mumbai, Maharashtra, India, established in 2022.
2022 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Farmaceutica Evolucion Llp

Farmaceutica Evolucion Llp, a active limited liability partnership, was established on 17 June 2022 in Mumbai, Maharashtra, India. Engaging in commission trade within the business services sector, it holds LLPIN: ABB-4118. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Bharat Shantilal Shah (Designated Partner), Urvi Bharat Shah (Designated Partner), Sanket Anandrao Umredkar (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at 6Th Floor, 627, Ajmera Sikova, Golibar Road, Off Lbs Marg, Ghatkopar West, Mumbai, Maharashtra, 400086.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ABB-4118

  • Incorporation Date

    17 June 2022

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 4 Year, 18 Days
  • Last Filing with ROC 31 Mar 2025
Company report

Farmaceutica Evolucion Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Farmaceutica Evolucion Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Farmaceutica Evolucion Llp?
Current Designated Partners
Name Designation Appointment Date Status
Bharat Shantilal Shah Designated Partner 17 Jun 2022 Current
Urvi Bharat Shah Designated Partner 17 Jun 2022 Current
Sanket Anandrao Umredkar Designated Partner 17 Jun 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Farmaceutica Evolucion Llp.

Enhance accessibility to Farmaceutica Evolucion Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Farmaceutica Evolucion Llp revenue growth over time
Farmaceutica Evolucion Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Farmaceutica Evolucion Llp?

Unlock access to Farmaceutica Evolucion Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Farmaceutica Evolucion Llp?

Unlock and access historical data on people associated with Farmaceutica Evolucion Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Farmaceutica Evolucion Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Farmaceutica Evolucion Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Farmaceutica Evolucion Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Farmaceutica Evolucion Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    Farmaceutica Evolucion Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    The activity Bharat Shantilal Shah was appointed as a Designated Partner was appointed as a Designated Partner on 17 Jun 2022 & has been associated with this company since 4 years 18 days . was completed.

  • Director Appointment

    The activity Urvi Bharat Shah was appointed as a Designated Partner was appointed as a Designated Partner on 17 Jun 2022 & has been associated with this company since 4 years 18 days . was completed.

  • Director Appointment

    Sanket Anandrao Umredkar was appointed as a Designated Partner was appointed as a Designated Partner on 17 Jun 2022 & has been associated with this company since 4 years 18 days . was recorded as a recent event.

  • LLP Incorporation

    The activity Farmaceutica Evolucion Llp was registered on 17 Jun 2022 with Roc Mumbai & aged 4 years 18 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Farmaceutica Evolucion Llp?

The LLPIN of Farmaceutica Evolucion Llp is ABB-4118.

Where is Farmaceutica Evolucion Llp headquartered?

Farmaceutica Evolucion Llp is headquartered at 6Th Floor, 627, Ajmera Sikova, Golibar Road, Off Lbs Marg, Ghatkopar West, Mumbai, Maharashtra, 400086.

When was Farmaceutica Evolucion Llp incorporated?

Farmaceutica Evolucion Llp was incorporated on 17 June 2022.

Who are the current directors of Farmaceutica Evolucion Llp?

The current directors of Farmaceutica Evolucion Llp are

What is the primary industry of Farmaceutica Evolucion Llp?

The primary industry of Farmaceutica Evolucion Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available